Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
academic, adaptive, advocacy, Alan, alopecia, Anderson, anti, anticancer, Antonio, assigned, Austria, Bansal, bar, Bayesian, Belgium, Berry, bone, Boston, broker, Buck, Burnett, buy, Carol, case, Centre, challenge, characteristic, Chief, cleared, Cohn, concept, consortium, constitute, conventional, copy, creation, DA, Dana, daunorubicin, de, deadly, dealer, decided, decline, dedicated, Denmark, des, description, die, Diller, diminished, discount, disordered, Donald, door, driven, du, EBCC, Eli, eligibility, eligible, entitled, error, Esserman, Exhibit, experimental, expertise, failure, Family, Farber, fashion, feasibility, founder, Framework, Francisco, Frank, Glovsky, graduate, Haematological, Health, healthcare, Helen, hematopoietic, home, immature, indemnification, ineffective, innovative, intensive, irreversible, IV, Kaplan, Kettering, largest, Laura, leaving, led, letter, leukemic, leukopenia, Levin, Lilly, long, Lymphoma, mainstay, marrow, match, MD, MDS, Medicine, medium, Meier, member, micromolar, Mintz, Montreal, multicenter, Myelodysplastic, NCI, NCRI, negotiated, neoplasm, network, neurotoxicity, NYC, older, opening, pilot, pipeline, placement, plot, poor, Popeo, portion, potent, PRCL, predefined, President, prevented, proceed, proceeding, Professor, Programme, prolonged, proof, purely, QLHC, qualification, QuantumLeap, radiolabeled, Radiology, rapid, recruitment, remission, render, resigned, robust, San, Sanjay, science, seat, sequentially, Serial, Sloan, solicitation, Solidarit, sought, sponsorship, stability, standing, stem, stemmed, stockholder, strength, stronger, superiority, supplement, sustained, Syndrome, text, thrombocytopenia, traditionally, translocation, trap, trastuzumab, turnaround, TVM, UCSF, umbrella, uncontrolled, underwriter, unlawful, uptake, UT, Venture, VII, vote, vulnerable, weak, week, worldwide, younger, Zealand
Removed:
addressed, AKT, alpha, androgen, anemia, antibody, ASH, ATR, attack, bacteria, bind, bladder, body, BRAF, capecitabine, central, checkpoint, CHIARA, cisplatin, collectibility, colorectal, combine, consistency, constrained, contrast, cooperative, coordination, Crohn, cumulative, defense, dehydrogenase, destabilization, differentiation, discontinuation, disrupt, disruption, distinct, divided, DNA, DoD, driver, durable, elderly, elevate, Emory, enhanced, enriching, entry, ER, escalation, essential, establishment, estrogen, etoposide, excluded, exercised, extension, face, February, formation, fringe, functional, gastric, gatekeeping, gemcitabine, generation, genetically, guidance, head, helper, Hematology, Herceptin, Hospital, immunodeficiency, improve, improved, improvement, increasing, independent, inflammation, inform, inhibit, injectable, irinotecan, labeled, lactate, malignant, Margaret, master, maturation, meeting, melanoma, mesothelioma, methodology, modifying, monitoring, MSKCC, mutated, myeloma, neck, nonstatutory, November, obtaining, oncogene, oncogenic, orally, overactive, overexpressed, participated, PDFGR, pharmacokinetic, play, pleural, potentially, powered, powering, prespecified, produce, proposal, prostate, protocol, radiation, RAF, recently, reclassified, recognize, rectal, regulate, reliant, rely, remained, renal, repair, requiring, revealed, reviewed, role, salary, schedule, selective, sensitive, showed, signaling, sodium, sponsoring, spread, stable, structural, studied, substantial, survivin, switch, synergistic, tamoxifen, TNBC, tolerability, Topic, Toronto, toxicity, unmet, validate, variable, VEGF, VEGFR, vessel, vincristine, work, World, York
Filing tables
Filing exhibits
MDGL similar filings
Filing view
External links
Exhibit 10.4
|
Synta Pharmaceuticals Corp. 45 Hartwell Avenue Lexington, MA 02421 |
| tel: 781 274 8200 |
| fax: 781 274 8228 |
|
|
| www.syntapharma.com |
VIA EMAIL DELIVERY
May 7, 2014
MLV & Co. LLC
1251 Avenue of the Americas, 41st Floor
New York, NY 10020
Attn: General Counsel
Re: At the Market Issuance Sales Agreement dated as of May 2, 2012, as amended (the “Sales Agreement”)
Ladies and Gentlemen:
This shall confirm our mutual agreement to terminate the Sales Agreement effective immediately, in accordance with Section 13(e) thereof. Pursuant to Section 13(e), Section 9, Section 11, Section 12, Section 18 and Section 19 shall remain in full force and effect.
If the foregoing is in accordance with your understanding, please sign and return to us a counterpart of this letter.
| Very truly yours, | |
|
| |
| SYNTA PHARMACEUTICALS CORP. | |
|
| |
| By: | /s/ Keith Ehrlich |
| Name: Keith Ehrlich | |
| Title: CFO | |
Agreed And Accepted:
MLV & CO. LLC
By: | /s/ Dean Colucci |
|
Name: Dean Colucci |
| |
Title: President |
| |